Primary care diagnosis of alpha-1 antitrypsin deficiency: Issues and opportunities

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 12, 2007, Pages 869-874

  Stoller, James K ^a,f   Fromer, Leonard ^b   Brantly, Mark ^c   Stocks, James ^d   Strange, Charlie ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS AT TYLER   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f Department of Pulmonary Allergy and Critical Care Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COMPETENCE; CLINICAL PRACTICE; HUMAN; LIVER DISEASE; PANNICULITIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; REVIEW; RISK FACTOR; STANDARD;

ALPHA 1-ANTITRYPSIN DEFICIENCY; CLINICAL COMPETENCE; HUMANS; LIVER DISEASES; PANNICULITIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 38949210332     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.12.869     Document Type: Review

References (14)

1. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and management of patients with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:816-900.
2. Stoller JK, Aboussouan LS. Alpha-1 antitrypsin deficiency. Lancet 2005; 365:2225-2236.
3. Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha-1 antitrypsin deficiency: a continuing problem. Chest 2005; 128:1989-1994.
4. Campos MA, Warmer A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with alpha-1 anti-trypsin deficiency between 1968 and 2003. Chest 2005; 128: 1179-1186.
5. Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha-1 antitrypsin deficiency: results of a mail survey of the readership of a national newsletter. Cleve Clin J Med 1994; 61:461-467.
6. Silverman EK, Miletich SP, Pierce JH, et al. Alpha-1 antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 1989; 140:961-966.
7. Juvelekian G, Stoller JK. Augmentation therapy in alpha-1 antitrypsin deficiency. Drugs 2004; 64:1-14.
8. Elkington H. White P. Chronic obstructive pulmonary disease and primary care. Br J Gen Pract 2002; 52:532-534.
9. Abadie V, Bertholet J, Feillet F, et al. Neonatal screening and long-term follow-up of phenylketonuria: the French database. Early Hum Dev 2001; 65:149-158.
10. O'Brien ML, Buist NRM, Murphey WH. Neonatal screening for alpha-1 antitrypsin deficiency. J Pediatr 1978; 92:1006-1010.
11. Shermock K, Gildea T, Singer M, Stoller JK. Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis. COPD 2005; 2:411-418.
12. Anonymous. Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). Chest 1998; 113 (suppl 2):123S-163S.
13. Lusuard M, De Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and CCPD: a comparative evaluation Italian study. Chest 2006; 129: 844-852.
14. Rahaghi FF, Ortega I, Schrager D, et al. The impact of including a physician alert accompanying pulmonary function (PFT) results on testing for and detection of alpha-1 antitrypsin deficiency. Chest 2007; 132(suppl):523c-524c.